Pangaea Oncology SA
MAD:PANG

Watchlist Manager
Pangaea Oncology SA Logo
Pangaea Oncology SA
MAD:PANG
Watchlist
Price: 1.7 EUR Market Closed
Market Cap: 58.5m EUR

Intrinsic Value

The intrinsic value of one PANG stock under the Base Case scenario is 2.35 EUR. Compared to the current market price of 1.7 EUR, Pangaea Oncology SA is Undervalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

PANG Intrinsic Value
2.35 EUR
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Pangaea Oncology SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about PANG?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PANG valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pangaea Oncology SA.

Explain Valuation
Compare PANG to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PANG?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pangaea Oncology SA

Current Assets 10m
Cash & Short-Term Investments 2m
Receivables 7.4m
Other Current Assets 624.7k
Non-Current Assets 19.6m
Long-Term Investments 3.4k
PP&E 1.2m
Intangibles 15.3m
Other Non-Current Assets 3.1m
Current Liabilities 5.7m
Accounts Payable 1.9m
Accrued Liabilities 109.6k
Other Current Liabilities 3.8m
Non-Current Liabilities 3.5m
Long-Term Debt 1.2m
Other Non-Current Liabilities 2.3m
Efficiency

Free Cash Flow Analysis
Pangaea Oncology SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pangaea Oncology SA

Revenue
14.9m EUR
Cost of Revenue
-5.2m EUR
Gross Profit
9.7m EUR
Operating Expenses
-11.9m EUR
Operating Income
-2.2m EUR
Other Expenses
952.7k EUR
Net Income
-1.3m EUR
Fundamental Scores

PANG Profitability Score
Profitability Due Diligence

Pangaea Oncology SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Net Margin is Increasing
31/100
Profitability
Score

Pangaea Oncology SA's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

PANG Solvency Score
Solvency Due Diligence

Pangaea Oncology SA's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
High Altman Z-Score
Negative Net Debt
57/100
Solvency
Score

Pangaea Oncology SA's solvency score is 57/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PANG Price Targets Summary
Pangaea Oncology SA

There are no price targets for PANG.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Pangaea Oncology SA
does not pay dividends
Shareholder Yield

Current shareholder yield for PANG is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PANG stock?

The intrinsic value of one PANG stock under the Base Case scenario is 2.35 EUR.

Is PANG stock undervalued or overvalued?

Compared to the current market price of 1.7 EUR, Pangaea Oncology SA is Undervalued by 28%.

Back to Top